A Study in Healthy Subjects to Investigate Whether Administration of Lucerastat Can Affect Normal Heart Function
Clinical trial NCT03832452 · COMPLETED
Trial details
- NCT number
- NCT03832452
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2019-04-22
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.